Brief: Arch Venture Fund VIII Reports 19.9 Percent Stake In Sienna Biopharmaceuticals Inc
07/03/2019 24:22
March 6 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* ARCH VENTURE FUND VIII REPORTS 19.9 PERCENT STAKE IN
SIENNA
BIOPHARMACEUTICALS INC AS OF FEB 22 - SEC FILING
Source text: (http://bit.ly/2XIurhl)
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures